P01AG082653↗

Trustees of Boston University received this grant or assistance award from National Institutes of Health: $17.18M obligated so far for aging research. Its latest action was on 2026-08-26.

Key facts · data as of Oct 25, 2026

Recipient
Trustees of Boston University
Awarding agency
National Institutes of Health (Department of Health and Human Services)
Obligated to date
$17.18M

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award P01AG082653, data as of Oct 25, 2026, https://spendquery.com/award?id=ASST_NON_P01AG082653_075

IMPROVING CAUSAL INFERENCE IN ALZHEIMER'S DISEASE PREVENTION RESEARCH ON MODIFIABLE RISK FACTORS: THE TRIANGULATION OF INNOVATIVE METHODS TO ENDAD (TIME-AD) PROJECT - OVERALL COMPONENT PROJECT SUMMARY RESEARCH ON ALZHEIMER’S DISEASE AND ALZHEIMER’S DISEASE RELATED DEMENTIAS (AD/ADRD) HAS IDENTIFIED SEVERAL PROMISING RISK FACTORS WHICH COULD GUIDE STRATEGIES TO PREVENT UP TO 40% OF AD/ADRD. NEARLY ALL PRIOR EVIDENCE RELIES ON OBSERVATIONAL DATA, WHICH IS PRONE TO BIASES FROM UNMEASURED CONFOUNDING, REVERSE CAUSATION, SELECTIVE SURVIVAL, AND MEASUREMENT ERROR. THE TRIANGULATION OF INNOVATIVE METHODS TO END AD (TIME-AD) PROGRAM ADDRESSES THESE CHALLENGES BY USING AN EVIDENCE TRIANGULATION FRAMEWORK FOR STRENGTHENING CAUSAL INFERENCE IN OBSERVATIONAL DATA. THIS FRAMEWORK SYSTEMATICALLY EVALUATES BIASES, PLANNING COMPLEMENTARY ANALYSIS APPROACHES WITH DIFFERENT DATA SOURCES AND STUDY DESIGNS TO RULE OUT ALTERNATIVE INTERPRETATIONS FOR THE ASSOCIATION OF EACH RISK FACTOR AND AD/ADRD: A) DOUBLY ROBUST OBSERVATIONAL METHODS COMBINING PROPENSITY SCORE MODELS WITH OUTCOME MODELS; B) INSTRUMENTAL VARIABLES (IV) METHODS USING GENETIC AND POLICY VARIATIONS THAT INTRODUCE RANDOM VARIATION IN EXPOSURE; AND C) QUANTITATIVE BIAS ANALYSIS TO CHARACTERIZE UNCERTAINTY. PROJECT 1 WILL ADDRESS THE EFFECTS OF ALCOHOL USE ACROSS THE LIFECOURSE ON COGNITIVE AGING AND AD/ADRD RISK. PROJECT 2 WILL EVALUATE THE EFFECTS OF DEPRESSION AND DEPRESSION TREATMENT ON AD/ADRD RISK AND POSSIBLE DIRECT AND MODIFYING ROLES OF CHRONIC PAIN. PROJECT 3 WILL ASSESS WHETHER AD/ADRD RISK MAY BE REDUCED BY PREVENTION OR TREATMENT OF VISION OR HEARING IMPAIRMENTS. PROJECT 4 WILL ASSESS THE IMPACTS OF SOCIAL ISOLATION, FOCUSING ON COMPONENTS OF SOCIAL ISOLATION THAT ARE MODIFIABLE WITH EXISTING INTERVENTIONS. EACH OF THESE EXPOSURES IS KNOWN TO BE ASSOCIATED WITH AD/ADRD OUTCOMES IN HIGHLY EDUCATED, PREDOMINANTLY WHITE POPULATIONS; THE CURRENT PROPOSALS WILL EXTEND OUR KNOWLEDGE BY FOCUSING ON CAUSATION, INCLUDING LARGE, DIVERSE SAMPLES, AND RIGOROUSLY EVALUATING HETEROGENEITY ACROSS POPULATIONS. IN ADDITION TO AN ADMINISTRATIVE CORE, PROJECTS WILL BE SUPPORTED BY A COGNITIVE OUTCOMES, EXPOSURE VARIABLES, AND COVARIATES DATA CORE, WHICH WILL HELP THE INTENSIVE DATA MANAGEMENT INVOLVED IN CONSTRUCTING ANALYTIC DATA SETS AND FOSTER HARMONIZED MEASURES AND COORDINATED ANALYSES, DRAWING ON MULTIPLE DATA SOURCES TO SUPPORT EVIDENCE TRIANGULATION. A GENETIC AND POLICY DATA CORE WILL BRING SPECIALIZED EXPERTISE ON GENETICS, POLICIES, AND IV ANALYSIS, PROVIDING CODE TO CONSTRUCT, VALIDATE, AND IMPLEMENT IV ANALYSES. AN ANALYTICS CORE WILL DEVELOP AND SHARE REUSABLE ANALYTIC CODE AND SUPPORT IMPLEMENTATION OF THE MOST UP-TO- DATE METHODOLOGY; AND AN EQUITY AND DISSEMINATION CORE WILL ENSURE AN EQUITY FOCUS IS MAINTAINED THROUGHOUT TIME-AD, MAXIMIZING THE RELEVANCE OF OUR FINDINGS TO IMPROVE OUTCOMES AMONG POPULATIONS TYPICALLY UNDERREPRESENTED IN AD/ADRD RESEARCH. THE EQUITY AND DISSEMINATION CORE WILL ENSURE THAT RESEARCH IMPLEMENTATION IS GUIDED BY POTENTIAL APPLICATIONS OF THE EVIDENCE AND THAT THE FINDINGS OF EACH STUDY ARE BROADLY DISSEMINATED TO STAKEHOLDERS WHO CAN ACT ON THE EVIDENCE. THE SYNERGIES CREATED BY SHARED CORES WITH EXPERTISE IN DATA, ANALYSIS, AND EQUITY AND DISSEMINATION ENSURE THAT TIME-AD WILL HAVE HIGH IMPACT.

Project Grant (B) · National Institutes of Health · to Trustees of Boston University (UEI FBYMGMHW4X95) · data as of 2026-10-25

Obligated to date$17.18M3 actions
Period2024-09-09 → 2026-08-26first to last action
Passed on$7.18Mto 1 subrecipient

What it is

Program
Aging Research (Assistance Listing 93.866)
Where the work is
Suffolk, MA · district MA-07

The research project

Project 4: Social isolation as a driver of AD/ADRD incidence and disparities · National Institute on Aging (NIA) · led by Jacqueline Marie Torres, BOSTON UNIVERSITY MEDICAL CAMPUS

“REVISED PROJECT SUMMARY Social isolation, defined as an objective state of limited to no social contact, impacts millions of older adults, with prevalence estimates varying from 10-25% across studies and measures.” Full abstract on RePORTER ↗

NIH funding by fiscal year: FY2024 $10.43M · FY2025 $10.94M · FY2026 $12.89M ($34.26M in all) · project period 2024-09-15 to 2029-08-31.

Source: NIH RePORTER, project P01AG082653. RePORTER counts NIH's awards by year; USAspending's obligations above count each action.

Obligations by fiscal year

FY2024$5.26M
FY2025$5.47M
FY2026$6.45M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subrecipients: where the money went next

5 subawards totaling $7.18M (41.8% of what was obligated), as Trustees of Boston University reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.

SubrecipientAmountSubawardsWhereFirstLast
Trustees of Boston University$7.18M5CA, MA2025-02-252025-05-07
The largest single subawards
DateToAmountFor
2025-02-28Regents of the University of California, San Francisco, the$3.98MADMINISTRATIVE CORE THE SUBCONTRACT FOR THE ADMINISTRATIVE (ADMIN) CORE WILL INCLUDE PARTIAL SUPPORT FOR CORE COINVESTIGATOR DR. TORRES, WHO IS A MULTIPLE PRINCIPAL INVESTIGATOR FOR THE OVERALL PROGRAM PROJECT. DR.…
2025-04-04Kaiser Foundation Hospitals$1.91MCORE 1. ADMINISTRATIVE CORE THE SUBCONTRACT FOR THE ADMINISTRATIVE (ADMIN) CORE WILL INCLUDE PARTIAL SUPPORT FOR CORE CO-INVESTIGATOR DR. GILSANZ, WHO IS A MULTIPLE PRINCIPAL INVESTIGATOR FOR THE OVERALL PROGRAM…
2025-02-25University of California, Los Angeles$702.1KANALYTICS CORE: DR. MAYEDA WILL CO-LEAD THE ANALYTICS CORE WITH DR. CHIUNG-YU HUANG AT UCSF AND DR. NIANOGO WILL SERVE AS A CO-INVESTIGATOR ON THE ANALYTICS CORE. DR. MAYEDA WILL PARTNER WITH DR. HUANG TO ENSURE THAT…
2025-03-31Kaiser Foundation Hospitals$372.3KGENETICS AND POLICY DATA CORE: DR. BRENOWITZ, THE COLLABORATING INSTITUTION’S PROJECT LEAD, IS A COINVESTIGATOR IN THE GENETICS AND POLICY DATA CORE. SHE WILL PARTICIPATE IN REGULAR CORE MEETINGS AND PROVIDE…
2025-05-07President and Fellows of Harvard College$215.4KPROJECT 1: ALCOHOL USE AND AD/ADRD RISK: INNOVATIVE METHODS AND DATA FOR NEW INSIGHTS DR. ROBINS WILL BE RESPONSIBLE FOR ENSURING THE TECHNICAL CORRECTNESS OF G-METHOD IMPLEMENTATION IN PROJECT 1. HE WILL DISCUSS…

Every action

3 actions since 2024-09-09. Each is a modification or amendment with the money it added or took back.

DateAmendmentKindAmountWhat the agency wrote
2026-08-26000Continuation$6.45MIMPROVING CAUSAL INFERENCE IN ALZHEIMER'S DISEASE PREVENTION RESEARCH ON MODIFIABLE RISK FACTORS: THE TRIANGULATION OF INNOVATIVE METHODS TO ENDAD (TIME-AD) PROJECT - RESEARCH ON ALZHEIMER’S DISEASE AND ALZHEIMER’S DISEASE RELATED DEMENTIAS (AD/ADRD) HAS…
2025-08-15000Continuation$5.47MIMPROVING CAUSAL INFERENCE IN ALZHEIMER'S DISEASE PREVENTION RESEARCH ON MODIFIABLE RISK FACTORS: THE TRIANGULATION OF INNOVATIVE METHODS TO ENDAD (TIME-AD) PROJECT - RESEARCH ON ALZHEIMER’S DISEASE AND ALZHEIMER’S DISEASE RELATED DEMENTIAS (AD/ADRD) HAS…
2024-09-09000New award$5.26MIMPROVING CAUSAL INFERENCE IN ALZHEIMER'S DISEASE PREVENTION RESEARCH ON MODIFIABLE RISK FACTORS: THE TRIANGULATION OF INNOVATIVE METHODS TO ENDAD (TIME-AD) PROJECT - OVERALL COMPONENT PROJECT SUMMARY RESEARCH ON ALZHEIMER’S DISEASE AND ALZHEIMER’S DISEASE…

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗